Physician profile
Randy Kyle Bottner
NPI 1780673921
$11,391.63
in general payments reported to CMS, 2019-2025
44 companies · $1,854 in 2025
The $1,854 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,147 · 2020: $704 · 2021: $1,136 · 2022: $1,863 · 2023: $1,826 · 2024: $1,863 · 2025: $1,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,541.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,106.43 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,002.21 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $952.66 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $895.79 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $682.99 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $593.22 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $518.13 | 2021-2024 | Impella |
| Pfizer INC. | $513.00 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $494.50 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $487.02 | 2019-2025 | Jardiance |
| Medtronic, INC. | $477.76 | 2021-2025 | Micra, Reveal Linq, Linq II |
| Atricure, INC. | $405.08 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $351.97 | 2019-2025 | Watchman Flx |
| Amgen INC. | $333.81 | 2019-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $302.41 | 2021-2025 | Opsumit, Opsynvi |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $289.39 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions |
| Cardiva Medical, INC. | $259.35 | 2021-2024 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $257.25 | 2019-2024 | |
| Vital Connect, INC | $118.73 | 2023-2024 | Vitalpatch Rtm |
| Abbott Laboratories | $110.50 | 2019 | |
| Ge Healthcare | $109.49 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $106.50 | 2023-2024 | Inpefa |
| Cvrx, INC. | $84.91 | 2023-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $80.77 | 2020-2025 | Nexletol |
| Astellas Pharma US INC | $79.92 | 2019-2021 | |
| Bardy Diagnostics, INC. | $78.73 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $74.58 | 2021-2025 | Onpattro |
| Medicomp INC | $72.16 | 2022-2023 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $67.64 | 2022-2025 | |
| Amarin Pharma, INC. | $59.19 | 2019-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $57.54 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $53.11 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Shockwave Medical, INC | $51.61 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $41.95 | 2019-2020 | |
| Baxter Healthcare | $30.88 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $27.63 | 2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $25.54 | 2019 | |
| Bridgebio Pharma, INC. | $25.47 | 2025 | Attruby |
| Inspire Medical Systems, INC. | $23.20 | 2025 | Inspire |
| Lundbeck LLC | $19.97 | 2019 | |
| Scpharmaceuticals INC. | $19.80 | 2025 | |
| Vifor Pharma, INC. | $18.90 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $18.66 | 2024 | Arcalyst |
| Itamar Medical INC | $11.28 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Bottner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.